CannabisNewsBreaks

FridayApr 29, 2022 1:27 pm

CannabisNewsBreaks – American Cannabis Partners Leveraging Focus on Key Business Segments to Capture Opportunity

American Cannabis Partners (“ACP”), a sustainable Jamaican experience canna-business innovator, currently operates in Michigan and California and is also in the process of exploring land acquisition and project development strategies for expanding operations to two more states this year. “With a total of 12 cannabis licenses, including 560,000 square feet of cultivation licenses in California and Michigan and one retail license in Michigan, ACP is committed to becoming a leader in the U.S. cannabis industry,” reads a recent article discussing the company. “ACP is focused on multiple business segments: real estate, acquisition and development of proprietary assets, and ongoing cultivation…

Continue Reading

FridayApr 29, 2022 1:17 pm

CannabisNewsBreaks – Vantage Hemp Company Announces Submission of DMF, Reinforces Commitment to Deliver Superior API Quality

Vantage Hemp has submitted a Drug Master File (“DMF”) to the U.S. Food & Drug Administration (“FDA”) covering its hemp-derived cannabidiol (“CBD”) distillate. According to the announcement, the submission further reinforces Vantage as a transparent, reliable and compliant partner, committed to working with pharmaceutical companies to formulate its CBD active pharmaceutical ingredient (“API”). The filing, which also strengthens Vantage’s position as an industry leader, represents the company’s commitment to support its clients through all phases of drug development. The company also noted that it anticipates filing future DMF submissions as it works to deliver superior API quality. “Our distillate DMF…

Continue Reading

FridayApr 29, 2022 11:00 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Participate in Luxury Meets Cannabis Conference

Flora Growth’s (NASDAQ: FLGC) executives Luis Merchan and James Choe are scheduled to participate at the upcoming Luxury Meets Cannabis Conference. The two-day event is scheduled for May 5–6, 2022, in New York City. The premier B2B CBD, hemp and cannabis event — the first of its kind — is an ideal venue to shine a spotlight on FLGC’s impressive line of lifestyle products and brands. The conference is designed to bring together premium CBD, hemp and cannabis brands and their founders with representatives from top mainstream retailers, global media, leading dispensaries and investors. Flora Growth is a leading all-outdoor cannabis cultivator…

Continue Reading

ThursdayApr 28, 2022 3:05 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Unlock Capabilities of Revolutionary DehydraTECH(TM) Platform

Lexaria Bioscience Corp. (NASDAQ: LEXX) is aware of the need to continuously improve its understanding of the capabilities and potential applications of its patented DehydraTECH(TM) drug delivery technology. This informs its long-held commitment to its applied research and development (“R&D”) programs. “So far, the company’s research journey has involved a series of controlled and well-designed in vitro preclinical testing and in vivo animal and human clinical studies…. Still, Lexaria is unrelenting in its pursuit of comprehensive datasets that would answer many questions the company expects to face from potential commercial partners or regulators and is, in fact, expanding its research.…

Continue Reading

ThursdayApr 28, 2022 12:50 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Patent Portfolio with Novel Cannabinoid Analogs, Initiates Strategic Research Collaboration Agreement

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced the publication of a patent application in North America. The application has broad claims directed to the molecular structure, uses and methods of manufacturing of several cannabinoid analogs. Describing several new cannabinoid-related chemical compounds, the broad patent application, if granted, allows for the creation of several variations of novel cannabinoid compounds, producing a robust library of proprietary new chemical entities (“NCEs”). “We believe rare cannabinoids hold tremendous therapeutic potential that may address a number of unmet medical needs,” said Eric Hsu, SVP,…

Continue Reading

ThursdayApr 28, 2022 12:30 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Achieves Integration Milestone with First-Ever Sourcing of Its CBD into Market-Ready Products

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of cannabis products and brands, today announced that it has formally begun the integration of its licensed and Control Union Medical Cannabis Standard GACP (“CUMCS-GACP”) certified cannabis products and derivatives into its global roster of branded products. Beginning with CBD derivatives used in Mind Naturals, its award-winning skincare brand, the company has begun the process of integrating significantly lower-cost cannabinoids, grown and extracted at Flora’s cultivation and extraction facility, Cosechemos, for products formulated at the company’s GMP-licensed laboratory in Bogota, Colombia. The move marks a milestone in the company’s integration strategy,…

Continue Reading

TuesdayApr 26, 2022 2:09 pm

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) Working to ‘Reshape Future of Farming’ Through Innovative GrowPods

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, along with related equipment and supplies., is building a reputation for leading the movement toward sustainable, clean-food farming. The company is committed to working toward reshaping the future of farming through the innovative GrowPods, which the company distributes exclusively. These GrowPods provide a way to grow food that is free from pathogens and pesticides, which is even better than organic, the company explains. According to the announcement, the current centralized food system inherently has risks, including widespread foodborne illness as well as spoilage caused…

Continue Reading

TuesdayApr 26, 2022 1:20 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Names New CFO, Corporate Secretary

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced the appointment of a new chief financial officer and corporate secretary. The company named François C. Desrosiers, B. Com (Spec.) and FCSI, as Rryah CFO and corporate; the appointment is subject to approval  by the Canadian Securities Exchange (“CSE”). Desrosiers brings impressive experience in senior executive leadership roles to his new role with RYAH. He has served as cofounder, president, CEO and director at Northcore Resources Inc.; corporate secretary and officer…

Continue Reading

FridayApr 22, 2022 3:45 pm

CannabisNewsBreaks – American Cannabis Partners Looking to Expand to Additional States

American Cannabis Partners (“ACP”), a sustainable Jamaican experience canna-business innovator, is among companies that will benefit from a proposed cannabis bill by Nancy Mace, designed to ease federal regulations on the substance. “Despite the House and Senate being controlled by the Democrats, Nancy Mace, a Republican representative from South Carolina, has said her proposed cannabis bill will get a hearing,” a recent article reads. “Cannabis companies around the country are watching this momentum closely, including American Cannabis Partners, which operates in Michigan and California. ACP is also in the process of exploring land acquisition and project development strategies for expanding…

Continue Reading

FridayApr 22, 2022 2:28 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Well Positioned for Opportunity

Flora Growth Corp. (NASDAQ: FLGC) has expanded its portfolio, which spans a range of verticals and diverse revenue streams, with growth largely driven through mergers and acquisitions (“M&As”). With M&As defining its 2021 calendar year, Flora Growth capitalized on global trends, which saw over 63,000 worldwide M&A transactions completed across all industries and sectors as companies sought new avenues for growth amid the pandemic, rising inflation and disrupted supply chains. With two recent acquisitions, Flora Growth “was able to add an estimated $35 million in revenues and $7 million EBITDA. For comparison, back in 2020, the company’s acquisitions generated $28…

Continue Reading